PREDICTORS OF DISEASE PROGRESSION IN MILD ALZHEIMER'S DISEASE DEMENTIA PATIENTS - RESULTS FROM THE GERAS REAL WORLD COHORT AND EXPEDITION TRIALS

被引：1
|
作者：
Reed, C. [1 ]
Lebrec, J. [2 ]
Andrews, J. S. [3 ]
Bruno, G. [4 ]
Jones, R. W. [5 ]
机构：
[1] Eli Lilly & Co Ltd, Windlesham, Surrey, England
[2] Lilly Deutschland GmbH, Bad Homburg, Germany
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Univ Rome, Rome, Italy
[5] Res Inst Care Older People, Bath, Avon, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.458
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND5
引用
收藏
页码：A425 / A426
页数：2
相关论文
共 50 条
  • [41] Longitudinal Predictors of Quality of Life in Patients with Alzheimer's Disease: Results from the Canadian Alzheimer's Disease Quality of Life Study
    Naglie, G.
    Hogan, D.
    Krahn, M.
    Black, S.
    Freedman, M.
    Beattie, L.
    Borrie, M.
    Byszewski, A.
    MacKnight, C.
    Patterson, C.
    Bergman, H.
    Irvine, J.
    Ritvo, P.
    Streiner, D.
    Comrie, J.
    Kowgier, M.
    Tomlinson, G.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 : S10 - S10
  • [42] Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: Results from a methodological review
    Nicholls, Stuart G.
    Al-Jaishi, Ahmed A.
    Niznick, Harrison
    Carroll, Kelly
    Madani, Mohamad Tarek
    Peak, Katherine D.
    Madani, Leen
    Nevins, Pascale
    Adisso, Lionel
    Li, Fan
    Weijer, Charles
    Mitchell, Susan L.
    Welch, Vivian
    Quinones, Ana R.
    Taljaard, Monica
    [J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2023, 15 (01)
  • [43] Memantine in mild cognitive impairment and mild dementia of Alzheimer's disease: theoretical background, clinical trials and recommendations
    Sobow, Tomasz
    [J]. AKTUALNOSCI NEUROLOGICZNE, 2014, 14 (01): : 54 - 60
  • [44] Dementia from mild form till Alzheimer disease
    Barcikowska, Maria
    [J]. PHARMACOLOGICAL REPORTS, 2009, 61 (06) : 1223 - 1223
  • [45] Investigating predictors of progression from mild cognitive impairment to Alzheimer's disease based on different time intervals
    Wu, Yafei
    Wang, Xing
    Gu, Chenming
    Zhu, Junmin
    Fang, Ya
    [J]. AGE AND AGEING, 2023, 52 (09)
  • [46] Dementia from mild form till Alzheimer disease
    Maria Barcikowska
    [J]. Pharmacological Reports, 2009, 61 (6) : 1223 - 1223
  • [47] Disease progression model for Clinical Dementia Rating-Sum of Boxes in mild cognitive impairment and Alzheimer's subjects from the Alzheimer's Disease Neuroimaging Initiative
    Samtani, Mahesh N.
    Raghavan, Nandini
    Novak, Gerald
    Nandy, Partha
    Narayan, Vaibhav A.
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 929 - 952
  • [48] Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia
    Bergland, Anne Katrine
    Dalen, Ingvild
    Larsen, Alf Inge
    Aarsland, Dag
    Soennesyn, Hogne
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 56 (02) : 575 - 584
  • [49] Neuroglia in Alzheimer's Disease: From Cohort to Contestant in the Disease Progression and its Therapy
    Toledano, A.
    Merino, J. J.
    Rodriguez, J. J.
    [J]. CURRENT ALZHEIMER RESEARCH, 2016, 13 (04) : 318 - 320
  • [50] OBSERVATIONAL STUDY OF RESOURCE USE AND COST OF ALZHEIMER'S DISEASE IN EUROPE (GERAS)-18-MONTH RESULTS FROM THE FRENCH COHORT
    Rapp, T.
    Vellas, B.
    Andrieu, S.
    Chartier, F.
    Baraille, L.
    Belger, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A409 - A409
12345